E-LIB Suche - Ergebnisse für: Damaj, Gandhi Laurent - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN ..:

Damaj, Gandhi Laurent ; Bachy, Emmanuel ; MA, Qiufei...
HemaSphere. 7 (2023) S3 - p. e216071d , 2023

Link: https://doi.org/10.1097/..

2

Treating relapsed/refractory mature T- and NK-cell neoplasm..:

Bachy, Emmanuel ; Savage, Kerry J. ; Huang, Huiqiang...
Blood Advances. 7 (2023) 16 - p. 4435-4447 , 2023

Link: https://doi.org/10.1182/..

3

PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPS..:

Thieblemont, Catherine ; MA, Qiufei ; Hampp, Christian...
HemaSphere. 7 (2023) S3 - p. e6096515 , 2023

Link: https://doi.org/10.1097/..

4

ZOHé: A Prospective Study of the Use of Biosimilar Filgrast..:

Damaj, Gandhi Laurent ; Benbrahim, Omar ; Hacini, Maya...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 6 - p. 362-369.e2 , 2017

Link: https://doi.org/10.1016/..

5

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN..:

Sarkozy, Clementine ; Thieblemont, Catherine ; Oberic, Lucie...
HemaSphere. 7 (2023) S3 - p. e06197a0 , 2023

Link: https://doi.org/10.1097/..

6

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, Jean Marie...
HemaSphere. 7 (2023) S3 - p. e41118bf , 2023

Link: https://doi.org/10.1097/..

7

Efficacy of minimal residual disease driven immune-interven..:

Olivier Tournilhac ; Magali Le Garff-Tavernier ; Stéphanie Nguyen Quoc...
Haematologica. 106 (2020) 7 - p. 1867-1875 , 2020

Link: https://doi.org/10.3324/..

8

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

9

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

10

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

11

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

12

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

13

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, J.M...
info:eu-repo/semantics/altIdentifier/doi/10.1097/01.hs9.0000967816.41118.bf. , 2023

Link: https://hal.science/hal-..

14

Randomized Phase III Trial Evaluating Subcutaneous Rituxima..:

Cartron, Guillaume ; Bachy, Emmanuel ; Tilly, Hervé...
info:eu-repo/semantics/altIdentifier/doi/10.1200/JCO.22.02327. , 2023

Link: https://hal.science/hal-..

15

Randomized Phase III Trial Evaluating Subcutaneous Rituxima..:

Cartron, Guillaume ; Bachy, Emmanuel ; Tilly, Hervé...
info:eu-repo/semantics/altIdentifier/doi/10.1200/JCO.22.02327. , 2023

Link: https://hal.science/hal-..

1-15